Founded in 2016, Sensby Biotechnology Co., Ltd. is mainly engaged in the development of photoelectric instruments, optical sensor devices and biosensor chips, biotechnology services, consulting, transfer and promotion services. The main products and projects include: surface plasmon resonance molecular interaction instrument, high resolution label free single molecule imaging equipment, wearable biosensor equipment and portable detection equipment. At present, it has been widely used in immunology, proteomics, drug screening, protein-nucleic acid interaction and other fields, which plays an effective role in the screening of peptide drug molecules on the cell surface. The R & D team of Sensby Biotechnology Co., Ltd. is led by experts at home and abroad. The core team members have scientific research experience in Germany, Austria, Singapore and other countries. Most of the scientific and technological personnel of the company are graduated from well-known universities at home and abroad. The team has strong product research and development ability.
 
Sensby adheres to continuous technological innovation to create value for customers. R & D personnel focus on technological innovation in the industry, and the number of patent applications has increased steadily. The company has won the trust and cooperation of customers with the increasing innovation ability, outstanding flexible customization ability and increasingly perfect delivery ability.
 
At present, the company's products have been sold all over the world, and constantly expand the market.